Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2023.560 | Clinical utility of lipoprotein(a) and its related polygenic risk score in risk stratification of cardiovascular complications among Chinese patients with type 2 diabetes |
Dr. TAM Claudia Ha Ting 譚夏亭 |
| 2023.558 | The effect of a theory-based educational program on nutritional knowledge, health-related behavior, and health outcomes in individuals with obesity in Hong Kong community settings | Ms. LUI Lai shan |
| 2023.561 | The effects of plant terrarium-based psychosocial Intervention on quality of life and well-being in patients in palliative care: a randomized controlled trial |
Ms. JIM Tsz Ting 詹子霆 |
| 2023.574 | A multicenter randomized controlled trial to assess the usefulness of computer-aided detection systems for colonoscopy in colorectal cancer screening in the Asia-Pacific region | Prof. LAU Louis H.S. |
| 2023.554 | Clinicopathologic analysis of Steroid cell Tumors of the Ovary |
Dr. LI Joshua Joshua Jing Xi Li |
| 2023.576 | Epidemiology and Treatment Outcome of Choroidal Metastases in Hong Kong | Dr. CHEE Arnold Shau Hei |
| 2023.595 | The effects of the lateral wedging insoles on the walking body balance of patients with moderate varus osteoarthritis knee |
Miss. WANG Han 王涵 |
| 2023.556 | Does comprehensive measurement of endometrial immune cells predict the clinical outcomes in women undergoing euploid embryo transfer? |
Prof. ZHANG TAO 張濤 |
| 2023.555 | A brief online compassion-focused therapy intervention for patients with kidney failure: A pilot randomised trial |
Dr. NG Marques Shek Nam Marques Shek Nam |
| 2023.548 | Impact of Wearable Activity Linked Kinetic Therapy on the Walking Performance and Vascular Health in Patients with Peripheral Artery Disease: A Randomized Clinical Trial (the WALK-PAD trial) |
Prof. TAN Guangming 譚廣明 |
| 2023.535 | Evaluation of HPV DNA self-sampling as a primary screening test for men: A Randomized Control Trial | Prof. WONG Eliza Lai Yi |
| 2023.541 | Longterm effectiveness of artificial intelligence-assisted colonoscopy on adenoma recurrence – A prospective longitudinal follow-up of randomized controlled trial | Prof. LAU Louis Ho Shing |
| 2023.553 | Utilization of a theory-driven, culturally tailored, social media-based, interactive telehealth intervention to increase longitudinal adherence to repeat faecal immunochemical test screening. A randomized controlled trial. | Prof. LAM Thomas Y.T. |
| 2023.547 | Identification of genetic and clinical biomarkers for predicting macular neovascularization in patients with central serous chorioretinopathy | Prof. CHEN Lijia |
| 2023.549 | A prospective pilot study to evaluate the diagnostic performance of a wireless sensor capsule in detection of upper gastrointestinal bleeding | Prof. LAU Louis H.S. |
| 2023.528 | SAfe immunomodulation reserVEd for Mild-to-mOderate, REcent-onset TED (SAVE-MORE-TED) - a multi-center, randomized, double-masked, placebo-controlled trial | Dr. CHONG Kelvin Kam Lung |
| 2023.544 | Deep Multimodal Learning Based Management of Myopia in Children | Dr. YAM Jason Cheuk Sing |
| 2023.531 | Mitigating the long-term effects of COVID-19 on childhood myopia: An evidence-based, multidisciplinary strategy |
Dr. ZHANG Xiujuan 張秀娟 |
| 2023.565 | A study of the safety, efficacy, and cost-effectiveness of using non-vitrectomised subretinal anti-VEGF injections to treat neovascular age-related macular degeneration. | Dr. Brelén Mårten Erik |
| 2023.533 | Taxonomic and functional profiling of healthy ocular surface microbiome in Hong Kong children | Prof. PANG Chi Pui |
| 2023.529 | Orbital RadiothErapy, Sirolimus and Intravenous steroid for primary Diplopia in Thyroid Eye Disease (RESIDE): a multi-center, assessor-masked, randomized-controlled trial | Dr. CHAN Karen Kar Wun |
| 2023.530 | Risk Assessment and Management Program (RAMP) on Knee Osteoarthritis in Primary Care– a one-year pragmatic randomized controlled trial | Dr. SIT Regina Wing Shan |
| 2023.532 | An integrated online program using psychoeducation and expressive writing for people with probable post-traumatic stress disorder and coexisting dissociative symptoms: a pilot randomised controlled trial |
Dr. LAM Stanley Kam Ki 林錦祺 |
| 2023.552 | Effect of an internet-based dialectical behaviour therapy-informed skills training for promoting smoking cessation and improving psychological distress of smokers: A pilot randomised controlled trial | Dr. HO Long Kwan |
| 2023.523 | Integrating social determinants of health (SDH) into electronic health records (EHRs): incorporating area-level SDH to augment predictive model identifying elderlies at high risk of readmissions | Dr. WU Yushan |
| 2023.525 | Can TElemedicine system replace doctor consultations to Achieve non-inferior blood pressure in patients with Controlled Hypertension (TEACH)? a randomised controlled trial and cost-minimization analysis | Prof. LEE Eric Kam Pui |
| 2023.527 | A Phase 3, randomised, double-blind, parallel-group, event-driven, cardiovascular safety study with BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity with established cardiovascular disease (CVD) or chronic kidney disease, and/or at least two weight-related complications or risk factors for CVD |
Prof. MA Ronald Ching Wan 馬青雲 |
| 2023.543 | Combined epidemiologic and molecular network analyses of newly diagnosed HIV infection in Hong Kong |
Dr. LEE Shui Shan 李瑞山 |
| 2023.539 | Metabolically healthy and unhealthy obese young individuals in Hong Kong: a prospective follow-up study |
Prof. KONG Alice Pik Shan 江碧珊 |
| 2023.551 | Impact of Injury Prevention Program on Ankle stability for ballet dancers | Ms. LUK Tsz Yan |
| 2023.526 | The prevalence of chronic endometritis and therapeutic benefits of antibiotics in women with unexplained recurrent miscarriage |
Prof. CHUNG Jacqueline Pui Wah 鍾佩樺 |
| 2023.537 | Enhancing reflective parenting in parents with mental illness: A feasibility study of an app-based intervention | Prof. TANG Jennifer Yee Man |
| 2023.546 | Identification of Biomarkers of Food Allergic Diseases | Dr. WAI Christine Yee Yan |
| 2023.545 | A prospective, observational study to examine factors associated with progression and regression from prediabetes in Hong Kong |
Dr. CHOW Elaine Elaine Chow |
| 2023.517 | Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients with Advanced/ Inoperable Solid Tumors | Prof. LAU James |
| 2023.542 | Targeting Adipose Browning with Rhein: An Innovative Chinese Medicine-based Approach to Treating Obesity and Metabolic Syndrome | Dr. HUI Xiaoyan |
| 2023.536 | Multimodal digital speech analysis for detection of depressive symptomatology in youth |
Dr. LI Man Ho Man Ho Li |
| 2023.520 | To study human blood vessel and valve diseases |
Prof. LUI Kathy Oi Lan 呂愛蘭 |
| 2023.515 | Feasibility test of innovative school-based interventions on health outcomes among primary students during post COVID-19 pandemic: A sequential mixed methods design | Prof. LAU Ying |
| 2023.524 | Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on Direct Oral Anticoagulants – A Prospective Multicenter Study | Dr. IP Bonaventure Yiu Ming |
| 2023.518 | A PHASE III, RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SATRALIZUMAB IN PARTICIPANTS WITH MODERATE-TO-SEVERE THYROID EYE DISEASE |
Dr. CHONG Kam Lung 莊金隆 |
| 2023.516 | Evaluation of a newly developed screening tool in identifying pre-schoolers with language difficulties: accuracy and availability | Prof. LEE Kathy Yuet Sheung |
| 2023.521 | Baveno VII criteria-guided initiation of non-selective beta blocker in patients with compensated advanced chronic liver disease to reduce hepatic decompensation: an open-label randomised controlled trial | Dr. LAI Jimmy Che To |
| 2023.512 | Development and Evaluation of an Artificial Intelligence-Assisted Scoliosis Screening and Management System (AI-SSMS) for Reducing Unnecessary Referrals and Healthcare Costs | Dr. LAM Tsz Ping |
| 2023.513 | A phase III, multicenter, randomized, open-label trial to evaluate the safety and efficacy of systemic therapy with regorafenib and pembrolizumab versus locoregional therapy with transarterial chemoembolization (TACE) or transarterial radioembolization (TARE), for the first-line treatment of intermediate-stage hepatocellular carcinoma with beyond up-to-7 criteria (REPLACE) | Prof. CHAN Stephen Lam |
| 2023.522 | Elder abuse in Hong Kong: challenges in detection and management by primary care physicians | Dr. NG Hok Wai |
| 2023.538 | An investigation into levels of proteins/analytes in maternal blood using Lateral Flow Immunoassays (LTFs) and Point of Care Readers (POC) for Maternal and fetal complications of Pregnancy |
Prof. POON Liona Chiu Yee Chiu Yee Liona POON |
| 2023.534 | An interventional, Phase 3 extension study to investigate long-term safety and tolerability of tolebrutinib in participants with relapsing multiple sclerosis, primary progressive multiple sclerosis, or nonrelapsing secondary progressive multiple sclerosis | Dr. CHOI Joseph Chun Ho CHOI |
| 2023.506 | The cut-off score and diagnostic accuracy of the smoothed cepstral peak prominence (CPPS) for Cantonese speakers with dysphonia | Prof. LAW Thomas |
| 2023.511 | Distal radioulnar joint morphology and its correlation with triangular fibrocartilage complex injury in Chinese | Dr. TSE Wing Lim |
Page 11 of 253.